459 filings
6-K
HCM
HUTCHMED (China) Limited
7 Jun 24
Current report (foreign)
6:25am
6-K
HCM
HUTCHMED (China) Limited
3 Jun 24
HUTCHMED Highlights Publication of Phase III FRUTIGA Results in Nature Medicine
6:13am
6-K
HCM
HUTCHMED (China) Limited
31 May 24
Current report (foreign)
6:12am
6-K
HCM
HUTCHMED (China) Limited
24 May 24
HUTCHMED Highlights Presentations at the 2024 ASCO Annual Meeting
6:06am
6-K
HCM
HUTCHMED (China) Limited
17 May 24
HUTCHMED Highlights Sovleplenib Phase III ESLIM-01 Study and Hematological Malignancy Programs Data to be Presented at the upcoming EHA2024 Congress
10:02am
6-K
h1sf3f 4f5l3z
14 May 24
Current report (foreign)
7:13am
6-K
h9milljt xuh9shblyx
10 May 24
Annual General Meeting held on May 10, 2024 – Poll Results
8:16am
6-K
g131trxi8 mewzxksv5
8 May 24
HUTCHMED Announces Appointment of Independent Non-executive Director and Member of Board Committee
6:31am
6-K
yp77v2
29 Apr 24
HUTCHMED Announces Positive CHMP Opinion for Fruquintinib in Previously Treated Metastatic Colorectal Cancer Received by Takeda
6:14am
6-K
8op4ts qmz
22 Apr 24
Vesting of awards under the Long Term Incentive Plan
6:15am
6-K
776crt
8 Apr 24
Current report (foreign)
6:03am
6-K
ni8ulw oho
5 Apr 24
HUTCHMED Highlights Data to be Presented at AACR Congress 2024
6:03am
6-K
gpimddy ko6w8
2 Apr 24
Current report (foreign)
6:03am
6-K
grkh ptm9dop
28 Mar 24
Current report (foreign)
6:02am
6-K
k46g 25urum7vc
22 Mar 24
HUTCHMED Initiates Registration Stage of the ESLIM-02 Phase II/III Trial of Sovleplenib for Warm Antibody Autoimmune Hemolytic Anemia in China
6:06am
6-K
wf68lh fe
14 Mar 24
Grant of Share Options under Share Option Scheme and Awards under Long Term Incentive Plan
6:04am
6-K
lmrzr0
5 Mar 24
Vesting of awards under the Long Term Incentive Plan
6:04am
6-K
getsy5f0ver3axpitvw
28 Feb 24
HUTCHMED Reports 2023 Full Year Results and Provides Business Updates
6:47am
6-K
pfddub mf9nmwp
7 Feb 24
HUTCHMED Highlights Presentation of Phase III Data on Fruquintinib in Second-Line Gastric Cancer at ASCO Plenary Series Session
6:43am